▶ 調査レポート

コラーゲン及びHAベース生体材料の世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Collagen and HA-based Biomaterials Market (Type: Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings, and Others; Application: Food, Medicine, Cosmetics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。コラーゲン及びHAベース生体材料の世界市場:市場規模、シェア、成長、動向、予測 / Collagen and HA-based Biomaterials Market (Type: Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings, and Others; Application: Food, Medicine, Cosmetics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027 / TPM-NV168資料のイメージです。• レポートコード:TPM-NV168
• 出版社/出版日:Transparency Market Research / 2019年10月28日
• レポート形態:英文、PDF、158ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥602,680 (USD5,795)▷ お問い合わせ
  Multi User¥914,680 (USD8,795)▷ お問い合わせ
  Global Site License¥1,226,680 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、コラーゲン及びHAベース生体材料の世界市場について調べ、コラーゲン及びHAベース生体材料の世界市場規模、市場動向、市場シェア、市場環境、市場予測、種類別(尿失禁、角膜シールド、美顔用皮膚充填剤、創傷包帯、その他)分析、用途別(食品、医薬品、化粧品、その他)分析、関連企業情報などをまとめました。
・コラーゲン及びHAベース生体材料の市場概要
・コラーゲン及びHAベース生体材料の市場動向
・コラーゲン及びHAベース生体材料の価格分析
・コラーゲン及びHAベース生体材料の世界市場規模・予測
・コラーゲン及びHAベース生体材料市場:種類別(尿失禁、角膜シールド、美顔用皮膚充填剤、創傷包帯、その他)
・コラーゲン及びHAベース生体材料市場:用途別(食品、医薬品、化粧品、その他)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Facial aesthetic treatments, in recent years, have been focused on high quality results with minimal steps involved. And while for years, collagen and hyaluronic acid (HA)-based biomaterials have been used for improving would healing and cosmetic surgeries, currently, there has been a flurry of activity, all aimed at enhancing patient outcomes. These innovations include several advanced dermal fillers that have been developed to cater to the skincare needs of people, globally. For instance, in May 2018, Nestlé Skin Health’s dermal filler Restylane® Lyft was approved by the Food and Drug Association for aesthetic and cosmetic purposes. According to this recent study by Transparency Market Research (TMR), the collagen and HA-based biomaterials market is set to grow at an average CAGR of ~5% during the forecast period of 2019 to 2027. The study projects a rise in investments toward research & development (R&D) that are predominantly aimed at discovering collagen and HA-based biomaterials that can be used in next-generation, innovative products such as injectable dermal fillers, in various cosmetic surgeries.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Collagen and HA-based Biomaterials Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Collagen and HA-based Biomaterials Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Key Industry Developments

5.2. Major Research Institutes Involved

5.3. Technological Advancements

5.4. Key Mergers & Acquisitions

5.5. Pricing Analysis

6. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Type

6.1. Introduction & Definition

6.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn)Forecast, by Type, 2017–2027

6.2.1. Urinary Incontinence

6.2.2. Corneal Shields

6.2.3. Facial Aesthetic Dermal Fillers

6.2.4. Wound Dressings

6.2.5. Others

6.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Type

7. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Application

7.1. Introduction

7.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

7.2.1. Food

7.2.2. Medicine

7.2.3. Cosmetics

7.2.4. Others

7.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Application

8. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Region

8.1. Introduction

8.2. Collagen and HA-based biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Region

9. North America Collagen and HA-based Biomaterials Market Analysis and Forecast

9.1. Introduction

9.2. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

9.2.1. Urinary Incontinence

9.2.2. Corneal Shields

9.2.3. Facial Aesthetic Dermal Fillers

9.2.4. Wound Dressings

9.2.5. Others

9.3. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

9.3.1. Food

9.3.2. Medicine

9.3.3. Cosmetics

9.3.4. Others

9.4. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. North America Collagen and HA-based Biomaterials Market Attractiveness Analysis

9.5.1. By Type

9.5.2. By Application

9.5.3. By Country/Sub-region

10. Europe Collagen and HA-based Biomaterials Market Analysis and Forecast

10.1. Introduction

10.2. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

10.2.1. Urinary Incontinence

10.2.2. Corneal Shields

10.2.3. Facial Aesthetic Dermal Fillers

10.2.4. Wound Dressings

10.2.5. Others

10.3. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

10.3.1. Food

10.3.2. Medicine

10.3.3. Cosmetics

10.3.4. Others

10.4. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis

10.5.1. By Type

10.5.2. By Application

10.5.3. By Country/Sub-region

11. Asia Pacific Collagen and HA-based Biomaterials Market Analysis and Forecast

11.1. Introduction

11.2. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

11.2.1. Urinary Incontinence

11.2.2. Corneal Shields

11.2.3. Facial Aesthetic Dermal Fillers

11.2.4. Wound Dressings

11.2.5. Others

11.3. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

11.3.1. Food

11.3.2. Medicine

11.3.3. Cosmetics

11.3.4. Others

11.4. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis

11.5.1. By Type

11.5.2. By Application

11.5.3. By Country/Sub-region

12. Latin America Collagen and HA-based biomaterials Market Analysis and Forecast

12.1. Introduction

12.2. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

12.2.1. Urinary Incontinence

12.2.2. Corneal Shields

12.2.3. Facial Aesthetic Dermal Fillers

12.2.4. Wound Dressings

12.2.5. Others

12.3. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

12.3.1. Food

12.3.2. Medicine

12.3.3. Cosmetics

12.3.4. Others

12.4. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis

12.5.1. By Type

12.5.2. By Application

12.5.3. By Country/Sub-region

13. Middle East & Africa Collagen and HA-based biomaterials Market Analysis and Forecast

13.1. Introduction

13.2. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

13.2.1. Urinary Incontinence

13.2.2. Corneal Shields

13.2.3. Facial Aesthetic Dermal Fillers

13.2.4. Wound Dressings

13.2.5. Others

13.3. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

13.3.1. Food

13.3.2. Medicine

13.3.3. Cosmetics

13.3.4. Others

13.4. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis

13.5.1. By Type

13.5.2. By Application

13.5.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player – Competition Matrix (By Tier and Size of companies)

14.2. Global Collagen and HA-based Biomaterials Market Share Analysis, by Company (2018)

14.3. Company Profiles

14.3.1. Collagen Solutions Plc

14.3.1.1. Company Description

14.3.1.2. Business Overview

14.3.1.3. Financial Overview

14.3.1.4. Strategic Overview

14.3.1.5. SWOT Analysis

14.3.2. Sanofi

14.3.2.1. Company Description

14.3.2.2. Business Overview

14.3.2.3. Financial Overview

14.3.2.4. Strategic Overview

14.3.2.5. SWOT Analysis

14.3.3. Allergan plc

14.3.3.1. Company Description

14.3.3.2. Business Overview

14.3.3.3. Financial Overview

14.3.3.4. Strategic Overview

14.3.3.5. SWOT Analysis

14.3.4. Anika Therapeutics, Inc.

14.3.4.1. Company Description

14.3.4.2. Business Overview

14.3.4.3. Financial Overview

14.3.4.4. Strategic Overview

14.3.4.5. SWOT Analysis

14.3.5. Bausch Health Companies Inc.

14.3.5.1. Company Description

14.3.5.2. Business Overview

14.3.5.3. Financial Overview

14.3.5.4. Strategic Overview

14.3.5.5. SWOT Analysis

14.3.6. Abbott Laboratories

14.3.6.1. Company Description

14.3.6.2. Business Overview

14.3.6.3. Financial Overview

14.3.6.4. Strategic Overview

14.3.6.5. SWOT Analysis

14.3.7. Johnson & Johnson Services, Inc.

14.3.7.1. Company Description

14.3.7.2. Business Overview

14.3.7.3. Financial Overview

14.3.7.4. Strategic Overview

14.3.7.5. SWOT Analysis

14.3.8. Galderma Laboratories L.P. (Nestle Skin Health)

14.3.8.1. Company Description

14.3.8.2. Business Overview

14.3.8.3. Financial Overview

14.3.8.4. Strategic Overview

14.3.8.5. SWOT Analysis

14.3.9. BioCell Technology LLC

14.3.9.1. Company Description

14.3.9.2. Business Overview

14.3.9.3. Financial Overview

14.3.9.4. Strategic Overview

14.3.9.5. SWOT Analysis